Authors:
Staley, JK
Van Dyck, CH
Tan, PZ
Al Tikriti, M
Ramsby, Q
Klump, H
Ng, C
Garg, P
Soufer, R
Baldwin, RM
Innis, RB
Citation: Jk. Staley et al., Comparison of [F-18]altanserin and [F-18]deuteroaltanserin for PET imagingof serotonin(2A) receptors in baboon brain: pharmacological studies, NUCL MED BI, 28(3), 2001, pp. 271-279
Authors:
Soares, JC
van Dyck, CH
Tan, PZ
Zoghbi, SS
Garg, P
Soufer, R
Baldwin, RM
Fujita, M
Staley, JK
Fu, X
Amici, L
Seibyl, J
Citation: Jc. Soares et al., Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and[F-18]deuteroaltanserin, PSYCH RES-N, 106(2), 2001, pp. 81-93
Authors:
van Dyck, CH
Soares, JC
Tan, PZ
Staley, JK
Baldwin, RM
Amici, LA
Fu, X
Garg, PK
Seibyl, JP
Charney, DS
Innis, RB
Citation: Ch. Van Dyck et al., Equilibrium modeling of 5-HT2A receptors with [F-18]deuteroaltanserin and PET: Feasibility of a constant infusion paradigm, NUCL MED BI, 27(8), 2000, pp. 715-722
Authors:
van Dyck, CH
Tan, PZ
Baldwin, RM
Amici, LA
Garg, PK
Ng, CK
Soufer, R
Charney, DS
Innis, RB
Citation: Ch. Van Dyck et al., PET quantification of 5-HT2A receptors in the human brain: A constant infusion paradigm with [F-18]altanserin, J NUCL MED, 41(2), 2000, pp. 234-241
Authors:
Tan, PZ
Baldwin, RM
Van Dyck, CH
Al-Tikriti, M
Roth, B
Khan, N
Charney, DS
Innis, RB
Citation: Pz. Tan et al., Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [F-18]altanserin in human and rodent, NUCL MED BI, 26(6), 1999, pp. 601-608
Authors:
Bremner, JD
Baldwin, R
Horti, A
Staib, LH
Ng, CK
Tan, PZ
Zea-Ponce, Y
Zoghbi, S
Seibyl, JP
Soufer, R
Charney, DS
Innis, RB
Citation: Jd. Bremner et al., Quantitation of benzodiazepine receptor binding with PET [C-11]iomazenil and SPECT [I-123]iomazenil: preliminary results of a direct comparison in healthy human subjects, PSYCH RES-N, 91(2), 1999, pp. 79-91
Citation: Pz. Tan et al., Rapid synthesis of F-18 and H-2 dual-labeled altanserin, a metabolically resistant PET ligand for 5-HT2A receptors, J LABEL C R, 42(5), 1999, pp. 457-467